Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Brand marketers are adopting fan-first social media strategies
Bigger brands are picking up a social playbook perfected by startup and scaleup marketers, having seen the results. But can it work at scale?
Creators build GEO strategies to get discovered by brands and agencies in AI search
With no established playbook for AI search, creators are starting to build their own.
How H&M, Chobani, UrbanStems and Teleties are refining their partnership strategies
Brands are refining partnerships to match audiences, drive cultural relevance and find new growth.